Literature DB >> 3511291

Intravesical bacillus Calmette-Guerin therapy and associated granulomatous renal masses.

T H Stanisic, M L Brewer, A R Graham.   

Abstract

We report a case of clinically symptomatic renal granulomas occurring during intravesical and intracutaneous bacillus Calmette-Guerin therapy for bladder cancer. The patient responded to antituberculous triple therapy. We emphasize the rarity of such extravesical infectious complications and discuss the possible routes of renal inoculation.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3511291     DOI： 10.1016/s0022-5347(17)45638-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  4 in total

1.  Granulomas of the kidney induced by Bacillus Calmette Guerin (BCG)

Authors:  G M Kondratowicz; D M Wallace
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

2.  BCG-related renal granulomas managed conservatively: A case series.

Authors:  Talal Al-Qaoud; Fadi Brimo; Armen G Aprikian; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature.

Authors:  Keiichi Narita; Hirotaka Akita; Eiji Kikuchi; Tadaki Nakahara; Shigeo Okuda; Seishi Nakatsuka; Mototsugu Oya; Masahiro Jinzaki
Journal:  BJR Case Rep       Date:  2019-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.